Sikiric P, Skrtic A, Gojkovic S, Krezic I, Zizek H, Lovric E, Sikiric S, Knezevic M, Strbe S, Milavic M, Kokot A, Blagaic AB, Seiwerth S
Related reading: CJC-1295 vs Ipamorelin vs Sermorelin vs IGF-1 LR3 the GH/IGF-1 axis explained BPC-157 vs GHK-Cu vs TB-500 tissue repair peptide mechanisms Epitalon vs Kisspeptin-10 vs NAD+ longevity pathways explained DSIP Peptide for Sleep delta sleep, HPA-axis, and recovery KPV vs LL-37 vs Thymosin Alpha-1 immune-supporting peptides Peptide Therapy Education 23 active compounds Considering Medical Weight Loss on Long Island
This diversity of targets reduces the risk of redundancy and maximizes coverage of repair mechanisms
BPC-157 peptide (Body Protection Compound-157) stands apart from nearly every other synthetic research peptide for one striking reason: it originates from a protein naturally found in human gastric juice, yet it demonstrates repair activity across at least nine distinct tissue systems in published preclinical studies
Injection sites can be local (near injury) or systemic (abdominal or thigh)